Intensive Glucose Control and Cardiovascular Outcomes in Type 2 Diabetes (Q37784325)

23 August 2017

title

Intensive glucose control and cardiovascular outcomes in type 2 diabetes (English)

1 reference

23 August 2017

Intensive Glucose Control and Cardiovascular Outcomes in Type 2 Diabetes (English)

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

4 July 2024

0 references

0 references

0 references

1 reference

George Jerums

2

1 reference

23 August 2017

Richard J. Macisaac

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20807681

4 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20807681

4 July 2024

publication date

31 August 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S1443950610014265?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

https://api.elsevier.com/content/article/PII:S1443950610014265?httpAccept=text/plain

4 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Heart, Lung and Circulation

4 July 2024

published in

1 reference

23 August 2017

volume

20

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

647-654

1 reference

Lifetime risk and projected population prevalence of diabetes

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006

4 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)

4 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Blood glucose and risk of cardiovascular disease in the Asia Pacific region

4 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study

4 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality

4 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study.

4 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

4 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

4 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

4 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

4 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Effects of intensive glucose lowering in type 2 diabetes

4 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

4 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Glucose control and vascular complications in veterans with type 2 diabetes

4 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

10-year follow-up of intensive glucose control in type 2 diabetes

4 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

4 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

4 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail

4 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

4 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

4 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Systematic review: glucose control and cardiovascular disease in type 2 diabetes

4 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials.

4 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

4 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

4 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus

4 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.HLC.2010.07.013

4 July 2024

Identifiers

1 reference

23 August 2017

1 reference